Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Charles, MO
NPI
1194793943
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
711 Veterans Memorial Pkwy Ste 200
Saint Charles, MO, 63303
Phone (636) 669-2219
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
561 services
Medicare patients, 2024
399
Average age 72
Drug cost, 2024
$3.9M
8,059 prescriptions
Company payments, 2025
$20K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jerome E Thurman was code 99214 (office e&m - established), 439 times for 318 patients. In total Jerome E Thurman billed 561 services in 10 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 439 | 318 | $63.83 | $28K |
| 99213 Office E&M - Established | Office | 72 | 70 | $27.65 | $1,991 |
| 99204 Office E&M - New | Office | 27 | 27 | $84.01 | $2,268 |
By year: 2022 $39K for 635 services; 2023 $38K for 630 services; 2024 $33K for 561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jerome E Thurman prescribed most often to Medicare patients was Levothyroxine Sodium, with 785 prescriptions and refills. In total Jerome E Thurman wrote 8,059 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 785 | 2,058 | 213 | $7,145 |
| Ozempic Semaglutide | 671 | 1,033 | 144 | $997K |
| Glimepiride Generic | 520 | 1,395 | 137 | $4,112 |
| Farxiga Dapagliflozin Propanediol | 392 | 675 | 79 | $369K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 364 | 720 | 99 | $415K |
| Metformin Hcl Generic | 275 | 707 | 73 | $2,044 |
| Metformin Hcl Er Metformin Hcl | 247 | 696 | 80 | $2,235 |
| Synthroid Levothyroxine Sodium | 237 | 573 | 56 | $22K |
| Methimazole Generic | 214 | 573 | 64 | $1,638 |
| Testosterone Cypionate Generic | 211 | 356 | 55 | $9,669 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 178 | 503 | 77 | $18K |
| Jardiance Empagliflozin | 172 | 365 | 46 | $217K |
| Tresiba Flextouch U-200 Insulin Degludec | 146 | 357 | 48 | $289K |
| Gabapentin Generic | 137 | 326 | 43 | $3,575 |
| Pioglitazone Hcl Generic | 134 | 335 | 37 | $1,602 |
Brand drugs: 3,983 claims; generic drugs: 3,579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jerome E Thurman $20K ($20K in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $19K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 35 | $19K |
| Sequel Med Tech, LLC | 29 | $658 |
| Medtronic, Inc. MDT | 11 | $405 |
| Dexcom, Inc. DXCM | 5 | $84.17 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $77.82 |
| Lilly USA, LLC LLY | 2 | $36.04 |
| Abbott Laboratories ABT | 1 | $34.69 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $30.02 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $24.04 |
| Abbvie Inc. ABBV | 1 | $16.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.